Expansion Cohort: Clinical Trials

1 trial of Expansion Cohort, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Expansion Cohort: new trials by email Literature Review of Expansion Cohort trials Research Report on Expansion Cohort

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma
Safety, Expansion Cohort - Malignant Pleural Mesothelioma
Phase 1CompletedOncovir, Inc.192020-08-192025-06-24

Conditions studied

Mesothelioma, Malignant (1)

Sponsors

Oncovir, Inc. (1)

Countries

United States (1)

Top investigators

Thomas Marron, MD (1)

Results publications

PMID 11487589, PMID 16554548, PMID 17295916, PMID 17395581, PMID 18797818, PMID 19360120, PMID 19564349, PMID 20549206, PMID 20615924, PMID 21135147, PMID 21149657, PMID 21467219, PMID 21632857, PMID 22065672, PMID 23032745, PMID 23248097, PMID 23785047, PMID 2418164, PMID 24366885, PMID 24484236, PMID 24487185, PMID 24739759, PMID 24777970, PMID 24852691, PMID 25281915, PMID 26968202, PMID 29975406, PMID 30962585, PMID 8727138